Perspective Therapeutics (FRA:AAJ) 3-Year EBITDA Growth Rate : -43.90% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics 3-Year EBITDA Growth Rate?

Perspective Therapeutics's EBITDA per Share for the three months ended in Mar. 2024 was €-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was -43.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Perspective Therapeutics was 79.30% per year. The lowest was -401.30% per year. And the median was 21.95% per year.

Competitive Comparison of Perspective Therapeutics's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Perspective Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perspective Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's 3-Year EBITDA Growth Rate falls into.

Perspective Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Perspective Therapeutics (FRA:AAJ) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Perspective Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ:Germany

Address

350 Hills Street, Suite 106, Richland, WA, USA, 99354

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines